[Chip]

Carfilzomib gets accelerated approval for multiple myeloma

by Chip on Tue Jul 24, 2012 11:33 am

The New York Times reported that the Food and Drug Administration granted approval to a "multiple myeloma drug, Kyprolis [carfilzomib] from Onyx Pharmaceuticals, [which] was approved for use when at least two other drugs have failed." Carfilzomib "received accelerated approval," after a study in which "the drug significantly shrank tumors in 23 percent of patients who had relapsed after receiving at least two previous therapies."

[Cindylou]

Re: Carfilzomib gets accelerated approval for multiple myelo

by Cindylou on Tue Jul 24, 2012 1:34 pm

The Myeloma Beacon published an extensive article about the news on Friday:
https://myelomabeacon.org/news/2012/07/20/fda-approves-kyprolis-carfilzomib-for-relapsed-and-refractory-multiple-myeloma/